Select Page

Description

Stilnox Zolpidem Steroid STILNOX is used to initiate and maintain sleep in those with sleeping difficulties, also called insomnia. It is not recommended for use for more than 4 weeks at a time.
STILNOX has a different chemical structure to other sleeping tablets. STILNOX works by binding to special sites in the brain which produce sleep.
Your doctor, however, may prescribe STILNOX for another purpose.. Zolpidem should be used with caution in patients with sleep apnea syndrome, and myasthenia gravis.
Respiratory Insufficiency: As hypnotics have the capacity to depress respiratory drive, precautions should be observed if zolpidem is prescribed to patients with compromised respiratory function (see Adverse Reactions).
Hepatic Insufficiency: Zolpidem must not be used in patients with severe hepatic impairment as it may contribute to encephalopathy (see Dosage & Administration, Contraindications and Adverse Reactions) Zolpidem is contraindicated in patients with: A hypersensitivity to zolpidem or any of the inactive ingredients; severe hepatic insufficiency; acute and/or severe respiratory insufficiency.
Full Prescribing Info
Contents
Zolpidem.
Description
Each film-coated tablet contains zolpidem tartrate 10 mg.
Indications/Uses
Zolpidem tartrate (Stilnox) is indicated for the treatment of insomnia.
Dosage/Direction for Use
General: Zolpidem tartrate (Stilnox) acts rapidly and therefore should be taken immediately before retiring, or in bed. Zolpidem tartrate (Stilnox) should be taken in a single intake and not be readministered during the same night.
Stilnox Zolpidem Steroid As with all hypnotics, long-term use of zolpidem is not recommended and a course of treatment should not exceed four weeks. In certain cases extension beyond the maximal treatment period may be necessary; if so, this should not take place without revaluation of the patient’s status.
The recommended daily dose for adults is 10 mg. The lowest effective daily dose of zolpidem should be used and must not exceed 10 mg.
Special Populations: Children: Safety and effectiveness of zolpidem in paediatric patients under the age of 18 years have not been established. Therefore, zolpidem should not be prescribed in this population (see Precautions).
Elderly: Since elderly or debilitated patients may be especially sensitive to the effects of zolpidem, in these subjects a 5 mg dose is recommended. The total zolpidem dose should not exceed 10 mg in this population.
Hepatic Impairment: As clearance and metabolism of zolpidem is reduced in hepatic impairment, dosage should begin at 5 mg in these patients, with particular caution being exercised in elderly patients. In adults (under 65 years) dosage may be increased to 10 mg only where the clinical response is inadequate and the drug is well tolerated.
Administration: For oral use only.
Overdosage
Signs and Symptoms: In cases of overdose involving zolpidem alone or with other CNS-depressant agents (including alcohol) impairment of consciousness up to coma, and more severe symptomatology, including fatal outcomes have been reported.
Management: General symptomatic and supportive measure should be used. If there is no advantage in emptying the stomach, activated charcoal should be given to absorption. Sedating drugs should be withheld even if excitation occurs. Use of flumazenil may be considered where serious symptoms are observed.
However, flumazenil administration may contribute to the appearances of neurological symptoms (convulsions).
Zolpidem is not dialyzable.
Contraindications
Zolpidem is contraindicated in patients with: A hypersensitivity to zolpidem or any of the inactive ingredients; severe hepatic insufficiency; acute and/or severe respiratory insufficiency.
Warnings Stilnox Zolpidem Steroid
Zolpidem should be used with caution in patients with sleep apnea syndrome, and myasthenia gravis.
Respiratory Insufficiency: As hypnotics have the capacity to depress respiratory drive, precautions should be observed if zolpidem is prescribed to patients with compromised respiratory function (see Adverse Reactions).
Hepatic Insufficiency: Zolpidem must not be used in patients with severe hepatic impairment as it may contribute to encephalopathy (see Dosage & Administration, Contraindications and Adverse Reactions).
Special Precautions
The cause of insomnia should be identified wherever possible and the underlying factors treated before a hypnotic is prescribed. The failure of insomnia to remit after a 7-14 day course of treatment may indicate the presence of a primary psychiatric or physical disorder, and the patient should be carefully re-evaluated at regular intervals.
Psychotic Illness: Hypnotics such as zolpidem are not recommended for the primary treatment of psychotic illness.
Amnesia: Sedative/hypnotic agents such as zolpidem may induce anterograde amnesia. The condition occurs most often several hours after ingesting the product and therefore to reduce the risk patients should ensure that they will be able to have an uninterrupted sleep of 7-8 hours.
Depression: As with other sedative/hypnotic drugs, zolpidem should be administered with caution in patients exhibiting symptoms of depression. Suicidal tendencies may be present, therefore the least amount of zolpidem that is feasible should be supplied to these patients to avoid the possibility of intentional overdosage by the patient. Pre-existing depression may be unmasked during use of zolpidem. Since insomnia may be a symptom of depression, the patient should be re-evaluated if insomnia persists. General information relating to effects seen following administration of hypnotic agents which should be taken into account by the prescribing physician are described as follows.
Other Psychiatric and “Paradoxical” Reactions: Other psychiatric and paradoxical reactions like restlessness, insomnia exacerbated, agitation, irritability, aggression, delusion, anger, nightmares, hallucinations, abnormal behavior and other adverse behavioral effects are known to occur when using sedative/hypnotic agents like zolpidem. Should this occur, use of zolpidem should be discontinued. These reactions are more likely to occur in the elderly.
Somnambulism and Associated Behaviours: Sleep walking and other associated behaviours such as “sleep driving”, preparing and eating food, making phone calls or having sex, with amnesia for the event, have been reported in patients who had taken zolpidem and were not fully awake. The use of alcohol and other CNS-depressants with zolpidem appears to increase the risk of such behaviours, as does the use of zolpidem at doses exceeding the maximum recommended dose. Discontinuation of zolpidem should be strongly considered for patients who report such behaviours (for example, sleep driving), due to the risk to the patient and others (see Interactions).
Psychomotor Impairment: The risk of psychomotor impairment, including impaired driving ability, is increased if: Zolpidem is taken within less than 7-8 hours before performing activities that require mental alertness, a dose higher than the recommended dose is taken, or zolpidem is co-administered with other CNS depressants, alcohol, or with other drugs that increase the blood levels of zolpidem.
Tolerance: Some loss of efficacy to the hypnotic effects of sedative/hypnotic agents like zolpidem may develop after repeated use for a few weeks.
Dependence: Use of sedative/hypnotic agents like zolpidem may lead to the development of physical and psychological dependence. The risk of dependence increases with dose and duration of treatment; it is also greater in patients with a history of psychiatric disorders and/or alcohol or drug abuse. These patients should be under careful surveillance when receiving hypnotics.
v Stilnox Zolpidem Steroid Once physical dependence has developed, abrupt termination of treatment will be accompanied by withdrawal symptoms. These may consist of headaches or muscle pain, extreme anxiety and tension, restlessness, confusion and irritability. In severe cases the following symptoms may occur: Derealization, depersonalization, hyperacusis, numbness and tingling of the extremities, hypersensitivity to light, noise and physical contact, hallucinations or epileptic seizures.

Additional information

Quantity

100 pills, 1000 pills, 150 Pills, 30 Pills, 500 pills